A common concern during hemiablative focal therapy for prostate cancer is the presence of significant tumours in contralateral sides of the prostate that have been missed by biopsy. In a recent study, a combination of diffusion-weighted imaging and extended 14-core biopsy was shown to efficiently predict lobes without significant cancer. The investigators recommend routine use of this approach to select patient for hemiablative therapy.